What Is The Predicted Revenue Outlook For The Genomic Cancer Panel And Profiling Market To Surpass $14.27 Billion?
Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors
What Is The Present And Forecasted Size Of The Genomic Cancer Panel And Profiling Market?
In recent years, the market size of genomic cancer panel and profiling has seen robust growth. The market is projected to expand from a value of $9.47 billion in 2024 to $10.28 billion in 2025, registering a compound annual growth rate (CAGR) of 8.6%. The exceptional growth during the historical period can be credited to factors like escalating global cancer rates, amplified use in clinical trials, development of diagnostic infrastructure, heightened awareness regarding genetic testing, and augmented government and research funding.
There is a promising surge projected for the market size of genomic cancer panel and profiling in the coming times. The expansion is anticipated to reach “$14.27 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.5%. This growth during the projected time frame is linked to the broader implementation of liquid biopsy applications, the escalating use in early disease detection, the expansion of personalized therapies, and the rise in approvals for companion diagnostics. The forthcoming period is also expected to see major trends such as the utilization of AI and machine learning for interpreting genomic data, the birth of multi-omics methodologies, the transition to cloud-based genomic data storage and analysis, the integration with electronic medical records, and the growth of Next-Generation Sequencing (NGS) platforms.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24225&type=smp
Which Key Factors Are Fueling Growth In The Genomic Cancer Panel And Profiling Market?
Expectations are that the genomic cancer panel and profiling market will experience growth due to a surge in cancer incidences. The disorder known as cancer exhibits abnormal cell growth and spread without control in the body. The escalating cancer incidence is linked to factors like an aging populace, which increases the likelihood of cancer as people’s lifespan extends. Genomic cancer panels and profiling assist in spotting genetic mutations and biomarkers in cancer, which helps in formulating personalized treatment plans and amplifying early detection and disease monitoring. For instance, data from the American Cancer Society, a nonprofit organization based in the U.S., revealed that in 2022, an estimated 20 million new cancer cases were globally reported, causing about 9.7 million fatalities. The anticipation is that the global cancer burden, mainly propelled by population growth, will escalate to 35 million incidences by 2050. Consequently, the upsurge in cancer incidence is projected to boost the genomic cancer panel and profiling market growth.
How Is The Genomic Cancer Panel And Profiling Market Organized By Different Segments?
The genomic cancer panel and profiling market covered in this report is segmented –
1) By Tissue Testing: Solid Tissue Testing, Liquid Tissue Testing
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Other Technologies
3) By Cancer Panel Type: Single-Gene Panel, Multi-Gene Panel
4) By Application: Clinical, Research
5) By End User: Hospitals, Research And Academic Institutes, Clinical And Diagnostic Laboratories, Other End Users
Subsegments:
1) By Solid Tissue Testing: Biopsy Samples, Surgical Resection Samples, Formalin-Fixed Paraffin-Embedded (FFPE) Tissues, Fresh Frozen Tissues
2) By Liquid Tissue Testing: Blood, Urine, Saliva, Cerebrospinal Fluid (CSF), Other Bodily Fluids
What Current And Upcoming Trends Are Shaping The Genomic Cancer Panel And Profiling Market?
Major players within the genomic cancer panel and profiling market are prioritizing the advancement of technology such as next-generation sequencers. This is in an effort to enhance the accuracy, speed, and scope of cancer diagnostics and contribute to more tailored treatment decisions. Next-generation sequencers are highly advanced DNA sequencing technologies that facilitate quick, high-throughput examinations of genetic content in order to detect mutations, variants and other genomic characteristics. For instance, QIAGEN N.V., a biotechnology company based in Netherlands, introduced QIAseq panels in April 2025, which are specially designed for next-generation sequencers. By scrutinizing over 700 genes, they offer comprehensive genomic profiling. These panels are directed at both research and clinical undertakings, with the intent of elevating the standards of cancer diagnostics and treatment approaches.
Which Firms Are Making The Biggest Impact In The Genomic Cancer Panel And Profiling Market?
Major companies operating in the genomic cancer panel and profiling market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX, HTG Molecular Diagnostics Inc., Predictive Oncology Inc.
Access The Complete Report Here:
Which Region Dominates The Genomic Cancer Panel And Profiling Market Today?
North America was the largest region in the genomic cancer panel and profiling market in 2024. The regions covered in the genomic cancer panel and profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=24225&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
